Afscheidssymposium: From bed to bench and back to the future: Huntington’s disease

Professor Raymund Roos neemt afscheid en dat wordt met een mooi symposium, in het LUMC gemarkeerd op 26 oktober 2018.

Het symposium heeft een aantal vooraanstaande internationale sprekers:

  • Dr S.J. Booij, CWZ Hospital Nijmegen
  • Prof.dr W.P. Achterberg, PHEG, LUMC
  • Prof.dr B.R. Bloem, Parkinson Center Nijmegen, Radboud University
  • Prof.dr G. Bernhard Landwehrmeyer, FRCP University Hospital Department of Neurology, Ulm (D)
  • D. Craufurd, department of Genetics, University of Manchester (UK)
  • Dr R. Reilmann, George-Huntington Institute, Münster (D)
  • Dr N. A. Aziz, LUMC, department of Neurology/DZE, Bonn (D)
  • Prof. A. Durr, Pitié-Salpetrière, Paris (F)
  • Dr K. Kieburtz, University Rochester Medical Centre, Rochester (USA)
  • Prof. S. Tabrizi, Huntington's Disease Center at University College London (UK)
  • Prof.dr A. Tibben, department of Clinical Genetics, LUMC
  • Prof.dr J.J. van Hilten, department of Neurology, LUMC
  • Dr W.M.C. van Roon-Mom, department of Clinical Genetics. LUMC
  • Prof.dr J.J.G.M. Verschuuren, department of Neurology, LUMC

http://files-eu.clickdimensions.com/lumcnl-af7ur/files/lumcboerhaavenascholinglogod3da8b2e.png                         afbeelding inschrijven.jpg          

Are you interested in future trends in healthcare and therapy of neurodegenerative disorders? Based on experience in Huntington’s disease gathered over the last 40 years? In this course speakers will address the developments in the care of patients with chronic disease in their final stages and the care of individual patients during the course of their disease. We will also discuss the patient within the family system as a network of care. Continue reading for further/more information.

In 1978 the diagnosis of Huntington’s disease was made on the clinical picture of chorea and a positive family history, hopefully confirmed earlier by examination of the morphology of the brain of a clinical certain case. A lot of progress has been made after the finding of the linkage in 1983 and the gene in 1993. From then on, the whole new field of premanifest testing in neurological disorders started. It gave a huge input into basic research with only one aim: to find a useful therapy. The steps made in the lab must be transferred to the clinic. The question is how to do that properly, with the restricted amount of money and clinical available patients. The field is eager to participate so the clinical trials must be structured very rigid so that the maximum result comes out each trial. The rarity of the disease hinders the progress! , the other side of the coin is that it made a strong point by organizing a worldwide collaboration possible, which otherwise never could have been reached. This day will also illustrate how other chronic diseases can learn from these findings and vice versa.

Farewell Lecture by Professor Raymund Roos.You are invited to register for the Farewell Lecture that will take place at Academie Gebouw, Rapenburg 73, Leiden.

Target audience
Neurologists, clinical genetics and for those who are in training

Confirmed: VKGN 6 points, NVN 5 points and ABC1 6 points 

For more information and registration please go to:

This course is endorsed by the Dutch Society for Movement Disorders.

werkgroep bewegingsstoornissen.jpg